Oncodesign Services is a French based, leading company in preclinical research and contributes to the development of innovative therapies in oncology, inflammation and infectious diseases. ZoBio is a Dutch based company that offers its customers solutions for fragment-based drug discovery, they use biophysical techniques for their innovative work in the field of drug discovery.
This acquisition of ZoBio allows Oncodesign to become a European leader in drug discovery and they will be able to expand their reach in Europe and further their expertise as well as what they are able to offer their customers.
Axon Lawyers (based in Amsterdam) advised ZoBio during this transaction.
“It was a pleasure to work with the driven and knowledgeable Zobio team on this deal.“ — – Carine van den Brink, partner Axon Lawyers